[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPS574914A - Manufacture of aqueous solution of water- insoluble or water-hard-soluble compound - Google Patents

Manufacture of aqueous solution of water- insoluble or water-hard-soluble compound

Info

Publication number
JPS574914A
JPS574914A JP7003981A JP7003981A JPS574914A JP S574914 A JPS574914 A JP S574914A JP 7003981 A JP7003981 A JP 7003981A JP 7003981 A JP7003981 A JP 7003981A JP S574914 A JPS574914 A JP S574914A
Authority
JP
Japan
Prior art keywords
water
insoluble
hard
manufacture
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7003981A
Other languages
Japanese (ja)
Inventor
Suzeyutori Yozefu
Bora Gebu Pusuzutai Eba
Sutadoreru Gebu Suzabo Agunesu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Publication of JPS574914A publication Critical patent/JPS574914A/en
Pending legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP7003981A 1980-05-09 1981-05-09 Manufacture of aqueous solution of water- insoluble or water-hard-soluble compound Pending JPS574914A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU801141A HU181703B (en) 1980-05-09 1980-05-09 Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents

Publications (1)

Publication Number Publication Date
JPS574914A true JPS574914A (en) 1982-01-11

Family

ID=10953012

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7003981A Pending JPS574914A (en) 1980-05-09 1981-05-09 Manufacture of aqueous solution of water- insoluble or water-hard-soluble compound

Country Status (7)

Country Link
JP (1) JPS574914A (en)
AT (1) AT374684B (en)
BE (1) BE888736A (en)
CH (1) CH661517A5 (en)
DE (1) DE3118218A1 (en)
FR (1) FR2484252A1 (en)
HU (1) HU181703B (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936656A (en) * 1982-08-23 1984-02-28 Teijin Ltd Novel clathrate compound and drug containing said compound as active component
JPS62123196A (en) * 1985-11-22 1987-06-04 Nisshin Flour Milling Co Ltd Prednisolone inclusion compound
JPS62190121A (en) * 1986-02-17 1987-08-20 Senjiyu Seiyaku Kk Water-based liquid agent
JPH02210A (en) * 1987-12-22 1990-01-05 Glaxo Group Ltd Aqueous recipe containing pyperidinylcyclopentylpentenic acid derivative
JPH023610A (en) * 1988-06-13 1990-01-09 Toyo Jozo Co Ltd Liquid syrup preparation of mequitazine
JPH06321812A (en) * 1993-05-18 1994-11-22 Daiichi Rajio Isotope Kenkyusho:Kk Radioactive iodine labeled aliphatic acid-cyclodextrin complex and imaging agent containing the complex
JPH0753396A (en) * 1993-08-19 1995-02-28 Ensuiko Sugar Refining Co Ltd Cyclodextrin clathrate of taxol, its production method and use
JPH07196495A (en) * 1993-12-14 1995-08-01 Eli Lilly & Co Clathrate compound water solution of benzothiophene compound and water-soluble cyclodextrin, medicinal preparation thereof, and its application of use
JPH08510232A (en) * 1993-05-12 1996-10-29 キノイン・ジヨージセル・エーシユ・ベジエーセテイ・テルメーケク・ジヤーラ・エル・テー Inclusion complex consisting of taxol or taxotere or yew extract and cyclodextrin, production and use of the complex
JPH0948737A (en) * 1995-05-26 1997-02-18 Sando Yakuhin Kk Cyclodextrin composition
US6566504B2 (en) 1996-04-19 2003-05-20 Alpha Therapeutic Corporation Process for viral inactivation of lyophilized blood proteins
JP2003238402A (en) * 2002-01-10 2003-08-27 Wacker Chemie Gmbh COMPLEX OF beta- OR gamma-CYCLODEXTRIN AND alpha-TOCOPHEROL AND METHOD FOR PRODUCING THE SAME AND COSMETIC CONTAINING THE SAME
JP2006328090A (en) * 1995-05-26 2006-12-07 Nobaruteisu Fuaama Kk Cyclodextrin composition
JP2007505040A (en) * 2003-09-08 2007-03-08 マジード，ムハンメド Preparation method of water-soluble diterpene and its application

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU194858B (en) * 1982-12-03 1988-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
SE8305864D0 (en) * 1983-10-25 1983-10-25 L E Medical eye drops
DE3477929D1 (en) * 1983-12-17 1989-06-01 Hoechst Ag Beta-cyclodextrin and process for its preparation
EP0146841A3 (en) * 1983-12-17 1986-11-20 Consortium für elektrochemische Industrie GmbH Water soluble mixed ether of beta-cyclodextrin, and process for its preparation
DE3346123A1 (en) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse PHARMACEUTICAL PREPARATIONS OF SUBSTANCES MEDICAL OR UNSTABLE IN WATER AND METHOD FOR THE PRODUCTION THEREOF
HU196128B (en) * 1985-01-10 1988-10-28 Chinoin Gyogyszer Es Vegyeszet Process for production of compound substituating bile and forwarding digestion of fat
JPH0651725B2 (en) * 1985-02-28 1994-07-06 メルシャン株式会社 Partially methylated cyclodextrin and method for producing the same
US6407079B1 (en) * 1985-07-03 2002-06-18 Janssen Pharmaceutica N.V. Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
DE3609116A1 (en) * 1986-03-14 1987-09-17 Herbe Wirkstoffe Gmbh Preparations of spices or drugs
DE68901043D1 (en) * 1988-01-14 1992-04-30 Akzo Nv AQUEOUS PHARMACEUTICAL PREPARATION.
CN1038304C (en) * 1988-01-19 1998-05-13 摩塞斯·朱旦·福克迈 Growth inhibiting compositions
DE3815902A1 (en) * 1988-05-10 1989-11-23 Schwarz Pharma Gmbh Inclusion compounds of 1-(4-(2-(5-chloro-2-methoxybenzamido)ethyl)phenylsulphonyl)-3-cyclohex ylurea with alpha -, beta - and gamma -cyclodextrins, a pharmaceutical product containing these in each case, and process for the production thereof
NL8801670A (en) 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan PHARMACEUTICAL PREPARATION.
FR2640137A1 (en) * 1988-12-08 1990-06-15 Texinfine Sa SYSTEMS CONVEYING LIPOPHILIC ACTIVE INGREDIENTS AND PROCESS FOR OBTAINING SAME
ZA903856B (en) * 1989-06-02 1991-05-29 Fujisawa Pharmaceutical Co Preparation of fri15224 substance for parenteral administration
SE8902235D0 (en) * 1989-06-20 1989-06-20 Haessle Ab NOVEL CYCLODEXTRIN INCLUSION COMPLEXES
US5041434A (en) * 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
USRE34578E (en) * 1990-05-07 1994-04-05 Lubkin; Virginia Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
DE4207922A1 (en) * 1992-03-13 1993-09-23 Pharmatech Gmbh New water-soluble inclusion complexes contg randomly substd. methyl-beta-cyclodextrin - for admin. of substances which are only sparingly soluble in water
DE4227569C1 (en) * 1992-08-20 1994-06-09 Inst Chemo Biosensorik Enzymatic determn. of inorganic phosphate - using combination of di:saccharide phosphorylase, phosphatase or maltose synthase, and glucose oxido-reductase
US5684169A (en) * 1992-11-27 1997-11-04 Ensuiko Sugar Refining Co., Ltd. Cyclodextrin inclusion complex of taxol, and method for its production and its use
JPH06157330A (en) * 1992-11-27 1994-06-03 Ensuiko Sugar Refining Co Ltd Cyclodextrin clathrate of taxol, it production and use thereof
DE4338508A1 (en) * 1993-11-11 1995-05-18 Asta Medica Ag Pharmaceutical preparations containing thioctic acid or dihydroliponic acid in the form of inclusion compounds with cyclodextrins or cyclodextrin derivatives and in the form of granules, chewable or effervescent tablets
DE4405545A1 (en) * 1994-02-22 1995-08-31 Dietl Hans Oral vitamin compsn. with improved resorption
KR19980033113A (en) * 1996-10-25 1998-07-25 야스다케 히지 Aqueous solutions of local anesthetics, how to improve the solubility of local anesthetics, local anesthetics with reduced neurotoxicity and methods of reducing the neurotoxicity of local anesthetics
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
US7074824B2 (en) 2001-07-31 2006-07-11 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
US6962944B2 (en) 2001-07-31 2005-11-08 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
FR2835434B1 (en) * 2002-02-01 2006-03-03 Lvmh Rech COSMETIC OR DERMATOLOGICAL USE OF VITAMIN A OR ITS ESTERS, IN ASSOCIATION WITH A PARTIALLY METHYLATED BETA-CYCLODEXTRIN
JP5412709B2 (en) 2003-03-28 2014-02-12 アレス トレーディング ソシエテ アノニム Cladribine formulations for improved oral and transmucosal delivery
AU2004226437B2 (en) 2003-03-28 2010-06-03 Ares Trading S.A. Oral formulations of cladribine
UA81305C2 (en) 2003-07-02 2007-12-25 Ares Trading Sa Formulation of cladribine (variants), cladribine-cyclodextrin complex, use of cladribine-cyclodextrin complex, mixture
DE102005017775A1 (en) * 2005-04-13 2006-10-19 Schering Ag New complex of vitamin-D-compounds with 5Z,7E,10(19)-triene system and methylene derivatives of beta-cyclodextrin, useful for the preparation of medicament and to treat psoriasis
JP6254609B2 (en) * 2012-12-27 2017-12-27 シエル・インターナシヨネイル・リサーチ・マーチヤツピイ・ベー・ウイＳｈｅｌｌ Ｉｎｔｅｒｎａｔｉｏｎａｌｅ Ｒｅｓｅａｒｃｈ Ｍａａｔｓｃｈａｐｐｉｊ Ｂｅｓｌｏｔｅｎ Ｖｅｎｎｏｏｔｓｈａｐ Composition
WO2014102149A1 (en) 2012-12-27 2014-07-03 Shell Internationale Research Maatschappij B.V. Compositions
CN113181110A (en) 2013-07-19 2021-07-30 勃林格殷格翰动物保健有限公司 Liquid aqueous pharmaceutical composition containing preserved etherified cyclodextrin derivatives

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50116617A (en) * 1974-02-25 1975-09-12

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50116617A (en) * 1974-02-25 1975-09-12

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936656A (en) * 1982-08-23 1984-02-28 Teijin Ltd Novel clathrate compound and drug containing said compound as active component
JPS62123196A (en) * 1985-11-22 1987-06-04 Nisshin Flour Milling Co Ltd Prednisolone inclusion compound
JPS62190121A (en) * 1986-02-17 1987-08-20 Senjiyu Seiyaku Kk Water-based liquid agent
JPH02210A (en) * 1987-12-22 1990-01-05 Glaxo Group Ltd Aqueous recipe containing pyperidinylcyclopentylpentenic acid derivative
JPH023610A (en) * 1988-06-13 1990-01-09 Toyo Jozo Co Ltd Liquid syrup preparation of mequitazine
JPH08510232A (en) * 1993-05-12 1996-10-29 キノイン・ジヨージセル・エーシユ・ベジエーセテイ・テルメーケク・ジヤーラ・エル・テー Inclusion complex consisting of taxol or taxotere or yew extract and cyclodextrin, production and use of the complex
JPH06321812A (en) * 1993-05-18 1994-11-22 Daiichi Rajio Isotope Kenkyusho:Kk Radioactive iodine labeled aliphatic acid-cyclodextrin complex and imaging agent containing the complex
JPH0753396A (en) * 1993-08-19 1995-02-28 Ensuiko Sugar Refining Co Ltd Cyclodextrin clathrate of taxol, its production method and use
JPH07196495A (en) * 1993-12-14 1995-08-01 Eli Lilly & Co Clathrate compound water solution of benzothiophene compound and water-soluble cyclodextrin, medicinal preparation thereof, and its application of use
JPH0948737A (en) * 1995-05-26 1997-02-18 Sando Yakuhin Kk Cyclodextrin composition
JP2006328090A (en) * 1995-05-26 2006-12-07 Nobaruteisu Fuaama Kk Cyclodextrin composition
US6566504B2 (en) 1996-04-19 2003-05-20 Alpha Therapeutic Corporation Process for viral inactivation of lyophilized blood proteins
JP2003238402A (en) * 2002-01-10 2003-08-27 Wacker Chemie Gmbh COMPLEX OF beta- OR gamma-CYCLODEXTRIN AND alpha-TOCOPHEROL AND METHOD FOR PRODUCING THE SAME AND COSMETIC CONTAINING THE SAME
JP2007505040A (en) * 2003-09-08 2007-03-08 マジード，ムハンメド Preparation method of water-soluble diterpene and its application

Also Published As

Publication number Publication date
CH661517A5 (en) 1987-07-31
AT374684B (en) 1984-05-25
FR2484252A1 (en) 1981-12-18
FR2484252B1 (en) 1984-06-29
DE3118218A1 (en) 1982-04-22
ATA204781A (en) 1983-10-15
BE888736A (en) 1981-08-28
HU181703B (en) 1983-11-28

Similar Documents

Publication Publication Date Title
JPS574914A (en) Manufacture of aqueous solution of water- insoluble or water-hard-soluble compound
GB2082564B (en) Removal of arsenic from aqueous solutions
JPS57100429A (en) Manufacture of structural body
MY8500518A (en) The treatment of aqueous systems
GB2105319B (en) Treatment of aqueous systems
JPS57109796A (en) Aqueous solution of cationic organosilicon compound and manufacture
DE3263735D1 (en) Manufacture of aqueous formaldehyde
DE3263774D1 (en) Manufacture of aqueous formaldehyde
JPS57149252A (en) Manufacture of succinylosuccinic acid dimethyl, disodium salt thereof and dihydroterephthalic acid or dianilinoterephthalic acid
JPS5714570A (en) Preparation of n-benzyloxycarbonylaspartic acid
DE3267846D1 (en) Manufacture of aqueous formaldehyde
JPS57123197A (en) Manufacture of 1-aminoalkane-1,1-diphosphoric acid
JPS5724396A (en) Manufacture of diacetone-ketogulonic acid
JPS57149264A (en) Manufacture of 1-alkyl-2-chloro-5-nitro-4- benzole-sulfonic acid
GB2083819B (en) Preparation of acetaldehyde
JPS5753438A (en) Manufacture of 2-aryloxy-acrylic acid compound
JPS56169644A (en) Manufacture of alkoxyalkanoic acid
JPS57174194A (en) Treatment of aqueous system
JPS5795813A (en) Manufacture of alkali metal salt of imidodisulfonic acid
IL61928A (en) Preparation of alpha-ketocarboxylic acid n-tert.-butylamides
JPS5757846A (en) Separation of metal from aqueous solution
GB2084560B (en) Disinfection of aqueous media
JPS56140968A (en) Manufacture of carbamoylsulfonic acid derivative salt
JPS5753437A (en) Manufacture of 2-aryloxy-2-halogenpropionic acid compound
JPS56104858A (en) Manufacture of styrylsulfonic acid derivative